In last trading session, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) saw 0.85 million shares changing hands with its beta currently measuring 0.35. Company’s recent per share price level of $0.39 trading at -$0.01 or -4.22% at ring of the bell on the day assigns it a market valuation of $17.67M. That closing price of IPA’s stock is at a discount of -523.08% from its 52-week high price of $2.43 and is indicating a premium of 17.95% from its 52-week low price of $0.32.
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) trade information
Upright in the red during last session for losing -4.22%, in the last five days IPA remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $0.39 price level, adding 13.33% to its value on the day. ImmunoPrecise Antibodies Ltd’s shares saw a change of -6.22% in year-to-date performance and have moved -13.04% in past 5-day. ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) showed a performance of -40.09% in past 30-days.
ImmunoPrecise Antibodies Ltd (IPA) estimates and forecasts
This year revenue growth is estimated to rise 0.92% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 6.58M for the same. And 2 analysts are in estimates of company making revenue of 6.77M in the next quarter. Company posted 6.22M and 6.46M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -11.23% during past 5 years.
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s Major holders
INGALLS & SNYDER LLC is the top institutional holder at IPA for having 1.3 million shares of worth $1.31 million. And as of 2024-06-30, it was holding 5.0209 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 63910.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.2477 of outstanding shares, having a total worth of $64549.0.
